Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry

Abstract Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a p...

Full description

Bibliographic Details
Main Authors: Miki Oono, Yoshimasa Fujita, Nobuaki Uchida, Ukichiro Kawai, Michiyo Fujita-Nakata, Megumi Nakanishi, Mitsuru Sanada, Shigemi Nagayama, Makoto Matsui
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-018-1196-3
_version_ 1818910153375744000
author Miki Oono
Yoshimasa Fujita
Nobuaki Uchida
Ukichiro Kawai
Michiyo Fujita-Nakata
Megumi Nakanishi
Mitsuru Sanada
Shigemi Nagayama
Makoto Matsui
author_facet Miki Oono
Yoshimasa Fujita
Nobuaki Uchida
Ukichiro Kawai
Michiyo Fujita-Nakata
Megumi Nakanishi
Mitsuru Sanada
Shigemi Nagayama
Makoto Matsui
author_sort Miki Oono
collection DOAJ
description Abstract Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient with RM using flow cytometry. Case presentation A 36-year-old woman with RA and generalized myasthenia gravis (MG) developed RM during a remission phase. Although both RA and MG were stable and well controlled, she noticed fever, headache, and transient sensory disturbance. Blood and CSF examination findings suggested aseptic meningitis, while brain magnetic resonance imaging revealed restricted portions of meningitis and associated cortical lesions, compatible with a diagnosis of RM. The dose of oral prednisolone was increased, which ameliorated the symptoms within 1 week along with improvement in CSF findings. This patient exhibited features of RM that were manifested in a manner independent of the activity of RA. An investigation of cellular immunity using CSF specimens with flow cytometry showed differences in regard to the pathogenesis of inflammation in the CSF as compared to outside of the central nervous system. In contrast to results obtained with paired blood samples, CSF cells at the peak stage of RM showed a marked increase in CCR3+ Th2 cells and marked decrease in CD8+ cells, suggesting an immunoregulatory disturbance in the CSF. Those findings indicated a CSF-specific activation of humoral immunity, resulting in augmentation of meningeal inflammation, as shown by excess synthesis of intrathecal IgG and markedly elevated interleukin-6 level. Results of the present detailed investigation of lymphocyte subsets revealed a discrepancy regarding the process of inflammation in this RM patient between CSF and blood samples. Conclusions RM is not a simple reflection of the immune status of RA, as the pathogenesis seems related to, at least in part, CSF-specific immunological dysregulation.
first_indexed 2024-12-19T22:38:17Z
format Article
id doaj.art-f412fb5f9d8e499598106cc58c32aaa9
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-19T22:38:17Z
publishDate 2018-05-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-f412fb5f9d8e499598106cc58c32aaa92022-12-21T20:03:09ZengBMCJournal of Neuroinflammation1742-20942018-05-011511610.1186/s12974-018-1196-3Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometryMiki Oono0Yoshimasa Fujita1Nobuaki Uchida2Ukichiro Kawai3Michiyo Fujita-Nakata4Megumi Nakanishi5Mitsuru Sanada6Shigemi Nagayama7Makoto Matsui8Department of Neurology, Kanazawa Medical UniversityDepartment of Hematology and Immunology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityDepartment of Neurology, Kanazawa Medical UniversityAbstract Background Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient with RM using flow cytometry. Case presentation A 36-year-old woman with RA and generalized myasthenia gravis (MG) developed RM during a remission phase. Although both RA and MG were stable and well controlled, she noticed fever, headache, and transient sensory disturbance. Blood and CSF examination findings suggested aseptic meningitis, while brain magnetic resonance imaging revealed restricted portions of meningitis and associated cortical lesions, compatible with a diagnosis of RM. The dose of oral prednisolone was increased, which ameliorated the symptoms within 1 week along with improvement in CSF findings. This patient exhibited features of RM that were manifested in a manner independent of the activity of RA. An investigation of cellular immunity using CSF specimens with flow cytometry showed differences in regard to the pathogenesis of inflammation in the CSF as compared to outside of the central nervous system. In contrast to results obtained with paired blood samples, CSF cells at the peak stage of RM showed a marked increase in CCR3+ Th2 cells and marked decrease in CD8+ cells, suggesting an immunoregulatory disturbance in the CSF. Those findings indicated a CSF-specific activation of humoral immunity, resulting in augmentation of meningeal inflammation, as shown by excess synthesis of intrathecal IgG and markedly elevated interleukin-6 level. Results of the present detailed investigation of lymphocyte subsets revealed a discrepancy regarding the process of inflammation in this RM patient between CSF and blood samples. Conclusions RM is not a simple reflection of the immune status of RA, as the pathogenesis seems related to, at least in part, CSF-specific immunological dysregulation.http://link.springer.com/article/10.1186/s12974-018-1196-3Rheumatoid meningitisMyasthenia gravisRheumatoid arthritisFlow cytometryCerebrospinal fluidInterleukin-6
spellingShingle Miki Oono
Yoshimasa Fujita
Nobuaki Uchida
Ukichiro Kawai
Michiyo Fujita-Nakata
Megumi Nakanishi
Mitsuru Sanada
Shigemi Nagayama
Makoto Matsui
Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
Journal of Neuroinflammation
Rheumatoid meningitis
Myasthenia gravis
Rheumatoid arthritis
Flow cytometry
Cerebrospinal fluid
Interleukin-6
title Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_full Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_fullStr Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_full_unstemmed Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_short Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_sort rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis detailed analysis of intracranial inflammation using flow cytometry
topic Rheumatoid meningitis
Myasthenia gravis
Rheumatoid arthritis
Flow cytometry
Cerebrospinal fluid
Interleukin-6
url http://link.springer.com/article/10.1186/s12974-018-1196-3
work_keys_str_mv AT mikioono rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT yoshimasafujita rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT nobuakiuchida rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT ukichirokawai rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT michiyofujitanakata rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT meguminakanishi rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT mitsurusanada rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT shigeminagayama rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT makotomatsui rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry